|
|
|
@ -16,7 +16,8 @@
|
|
|
|
- Objetivos y logros de los proyectos STOP previos en background
|
|
|
|
- Objetivos y logros de los proyectos STOP previos en background
|
|
|
|
- Qualification at EMA for art. 58
|
|
|
|
- Qualification at EMA for art. 58
|
|
|
|
- Safety of IVM up to 600μg/kg alone and in coformulation with albendazole
|
|
|
|
- Safety of IVM up to 600μg/kg alone and in coformulation with albendazole
|
|
|
|
- Demonstrated efficacy agrainst T. trichiura in a pivotal trial in SSA
|
|
|
|
- Demonstrated efficacy agrainst T. trichiura in a pivotal trial in Sub-Saharan Africa
|
|
|
|
|
|
|
|
- FDC of ivm/alb has the lowe
|
|
|
|
- Investigadores principales de cada uno de los partners
|
|
|
|
- Investigadores principales de cada uno de los partners
|
|
|
|
- Timeline y milestones (cuáles se han cumplido?)
|
|
|
|
- Timeline y milestones (cuáles se han cumplido?)
|
|
|
|
- __Proposed safety and effectiveness study__
|
|
|
|
- __Proposed safety and effectiveness study__
|
|
|
|
|
Borja Robert
11 months ago